• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 04625374160
Device Problems Improper or Incorrect Procedure or Method (2017); High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/27/2022
Event Type  malfunction  
Manufacturer Narrative
Initial reporter occupation: occupation is patient/consumer.The strips were requested for investigation, however, there are no test strips remaining to return.On a regular basis, coaguchek strips of lots currently valid in the market are tested as part of routine retention testing and results have passed the internal inspection.Per product labeling: coaguchek uses human recombinant thromboplastin.Therefore, the comparability to other human recombinant thromboplastins is best, whereas higher deviations can occur with other thromboplastins.However, those higher differences between thromboplastins of different (rabbit, bovine based) origin are not a coaguchek specific issue.Similar differences can be observed when a human recombinant thromboplastin-based laboratory method is compared against several other (rabbit, bovine-based) laboratory methods.
 
Event Description
We received an allegation of questionable inr results for 1 patient tested with coaguchek vantus meter serial number (b)(4) compared to an unknown laboratory method.On (b)(6) 2022 the patient had a meter result of 4.7 inr while the laboratory result was 3.6 inr.The time difference between the measurements was around 45 minutes.The patient thought that his finger was dry before testing but he wasn't sure about it and he didn't think he was dosing the strip within 15 seconds of poking his finger.The patient also mentioned that he squeezed the finger to get the blood drop and he was advised against excessive squeezing.The patient's therapeutic range was 2.5-3.5 inr and the interval of testing is once every 1-2 weeks.The patient did not know the lot number of the test strips that was used on (b)(6) 2022 and there wasn't any product left to return.
 
Manufacturer Narrative
The patient didn´t apply the blood sample within 15 sec.For a valid result the drop of blood has to be applied to the test strip within 15 sec.Otherwise the coagulation has already started in the sample on the pricked finger.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK ® XS SYSTEM
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
na
indianapolis, IN 46250
3174767531
MDR Report Key16419216
MDR Text Key310056108
Report Number1823260-2023-00535
Device Sequence Number1
Product Code GJS
UDI-Device Identifier00365702127104
UDI-Public00365702127104
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K170960
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 04/10/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Catalogue Number04625374160
Device Lot NumberASKU
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 01/25/2023
Initial Date FDA Received02/22/2023
Supplement Dates Manufacturer Received03/14/2023
Supplement Dates FDA Received04/10/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
WARFARIN
Patient Age85 YR
Patient SexMale
Patient Weight91 KG
-
-